Cargando…
The antiphospholipid antibody syndrome: a case report
Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658257/ https://www.ncbi.nlm.nih.gov/pubmed/23754926 http://dx.doi.org/10.2147/IMCRJ.S36129 |
_version_ | 1782270241528610816 |
---|---|
author | Luma, Henry Namme Doualla, Marie-Solange Temfack, Elvis Bagnaka, Servais Albert Fiacre Eloumou Mankaa, Emmanuella Wankie Fofung, Dobgima |
author_facet | Luma, Henry Namme Doualla, Marie-Solange Temfack, Elvis Bagnaka, Servais Albert Fiacre Eloumou Mankaa, Emmanuella Wankie Fofung, Dobgima |
author_sort | Luma, Henry Namme |
collection | PubMed |
description | Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in most surgical and medical specialties. The authors present the case of a 43-year-old man who, over a 13-year period of follow-up, presented with thrombosis of the mesenteric vein, inferior vena cava, and axillary and subclavian veins in a setting where diagnostic and therapeutic options are limited and costly. Through this case report, the authors aim to describe the evolution of this complex pathology, which to date has not been described in the authors’ milieu – probably because of its challenging diagnosis and the limited treatment options available. The authors conclude that clinicians need to have a high index of suspicion of APS in patients who present with a thrombotic episode – clinicians should investigate for the presence of antiphospholipid antibodies, as early diagnosis may influence the course of the disease. Furthermore, resources for the detection of antiphospholipid antibodies should be made readily available in resource-limited settings. Finally, patient education on the importance of drug compliance, periodic monitoring, and prevention of thrombosis is indispensable, especially as mortality could be associated with the effects of vascular thrombosis and/or the effects of bleeding due to anticoagulants. |
format | Online Article Text |
id | pubmed-3658257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36582572013-06-10 The antiphospholipid antibody syndrome: a case report Luma, Henry Namme Doualla, Marie-Solange Temfack, Elvis Bagnaka, Servais Albert Fiacre Eloumou Mankaa, Emmanuella Wankie Fofung, Dobgima Int Med Case Rep J Case Report Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in most surgical and medical specialties. The authors present the case of a 43-year-old man who, over a 13-year period of follow-up, presented with thrombosis of the mesenteric vein, inferior vena cava, and axillary and subclavian veins in a setting where diagnostic and therapeutic options are limited and costly. Through this case report, the authors aim to describe the evolution of this complex pathology, which to date has not been described in the authors’ milieu – probably because of its challenging diagnosis and the limited treatment options available. The authors conclude that clinicians need to have a high index of suspicion of APS in patients who present with a thrombotic episode – clinicians should investigate for the presence of antiphospholipid antibodies, as early diagnosis may influence the course of the disease. Furthermore, resources for the detection of antiphospholipid antibodies should be made readily available in resource-limited settings. Finally, patient education on the importance of drug compliance, periodic monitoring, and prevention of thrombosis is indispensable, especially as mortality could be associated with the effects of vascular thrombosis and/or the effects of bleeding due to anticoagulants. Dove Medical Press 2012-10-05 /pmc/articles/PMC3658257/ /pubmed/23754926 http://dx.doi.org/10.2147/IMCRJ.S36129 Text en © 2012 Luma et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Case Report Luma, Henry Namme Doualla, Marie-Solange Temfack, Elvis Bagnaka, Servais Albert Fiacre Eloumou Mankaa, Emmanuella Wankie Fofung, Dobgima The antiphospholipid antibody syndrome: a case report |
title | The antiphospholipid antibody syndrome: a case report |
title_full | The antiphospholipid antibody syndrome: a case report |
title_fullStr | The antiphospholipid antibody syndrome: a case report |
title_full_unstemmed | The antiphospholipid antibody syndrome: a case report |
title_short | The antiphospholipid antibody syndrome: a case report |
title_sort | antiphospholipid antibody syndrome: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658257/ https://www.ncbi.nlm.nih.gov/pubmed/23754926 http://dx.doi.org/10.2147/IMCRJ.S36129 |
work_keys_str_mv | AT lumahenrynamme theantiphospholipidantibodysyndromeacasereport AT douallamariesolange theantiphospholipidantibodysyndromeacasereport AT temfackelvis theantiphospholipidantibodysyndromeacasereport AT bagnakaservaisalbertfiacreeloumou theantiphospholipidantibodysyndromeacasereport AT mankaaemmanuellawankie theantiphospholipidantibodysyndromeacasereport AT fofungdobgima theantiphospholipidantibodysyndromeacasereport AT lumahenrynamme antiphospholipidantibodysyndromeacasereport AT douallamariesolange antiphospholipidantibodysyndromeacasereport AT temfackelvis antiphospholipidantibodysyndromeacasereport AT bagnakaservaisalbertfiacreeloumou antiphospholipidantibodysyndromeacasereport AT mankaaemmanuellawankie antiphospholipidantibodysyndromeacasereport AT fofungdobgima antiphospholipidantibodysyndromeacasereport |